跳至主要内容
临床试验/JPRN-UMIN000015794
JPRN-UMIN000015794已完成4 期

Efficacy of monthly sodium risedronate for the treatment of corticosteroid induced osteoporosis in patients with rheumatoid arthritis (multicenter, double-blind, randomized, placebo-controlled, parallel-group study ) - RISOTTO (sodium RISedrOnate for sTeroid induced osTeOporosis with rheumatoid arthritis)

Division of rheumatology, endcrinology and nephrology, Hokkaido University Graduate School of Medicine0 个研究点目标入组 165 人开始时间: 2014年12月10日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
165

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who received drugs for osteoporosis within 2 months at inclusion of the study except alphacalcidol and calcitriol Patients who had received bisphosphonates Patients who had undergone the operation of lumbar spine Patients who have a severe decayed tooth to be treated Patients who are considered to be contraindicated for bisphosphonates Patients who are thought to be inappropriate for this study by physicians

研究者

发起方
Division of rheumatology, endcrinology and nephrology, Hokkaido University Graduate School of Medicine

相似试验